
zzso is a zzso zzso study designed to assess the effect of zzso on imaging measures of plaque inflammation and plaque zzso zzso is a zzso imaging study in the context of the large zzso zzso zzso zzso zzso cholesterol is linked to increased risk of coronary heart disease zzso zzso a compound that increases zzso zzso cholesterol by modulating zzso zzso transfer zzso is being studied to assess if it can reduce the progression of zzso disease and thereby decrease cardiovascular morbidity and zzso Patients with zzso or zzso zzso were zzso to receive 600 zzso zzso or zzso daily for 24 months, in addition to conventional zzso medication and other medications for cardiovascular risk zzso The primary outcomes are the effect of zzso on zzso zzso zzso zzso zzso ratio after 6 months and magnetic resonance imaging zzso plaque burden zzso area, wall zzso total vessel area, and wall zzso vessel area zzso after 12 zzso Secondary objectives include zzso zzso zzso zzso ratio at 3 months and zzso plaque burden at 6 and 24 zzso plaque composition at 6, 12, and 24 zzso and zzso compliance at 6 zzso A zzso objective is to examine the dynamic zzso zzso parameters of plaque zzso In total, 189 subjects entered zzso and 130 were zzso zzso will provide important information on the effects of zzso on markers of inflammation and zzso plaque burden and, zzso on the safety of zzso zzso transfer protein zzso with zzso zzso are expected in zzso 

